Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
North America Cancer Biopsy Market, By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsy, Surgical Biopsy, Liquid Biopsy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancers, Others (Including Liver Cancer, Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 North America Cancer Biopsy Market Size Set Expands at Significant CAGR of ... Read More
-
Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032
... and New Zealand cutaneous T-cell lymphoma market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, driven by the increasing prevalence of the condition and the development of ... Read More
-
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]) Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031
... Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical)—Global Forecast to 2031. The Europe cancer diagnostics market is projected ... Read More
-
Artificial Intelligence In Oncology Global Market Report 2024
... Tumor4) By Application: Cancer Detection; Drug Discovery; Drug Development5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research InstitutesCovering: Azra AI; IBM Corporation; Siemens Healthcare GmbH; Intel Corporation; GE HealthCare Artificial Intelligence In Oncology Global Market ... Read More
-
Colorectal Cancer Molecular Diagnostics Global Market Report 2024
... Amplification Technology (INAAT)3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare SettingsCovering: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company Colorectal Cancer Molecular Diagnostics Global Market Report 2024 ... Read More
-
Ovarian Cancer Opportunity Assessment and Forecast
... by market for Ovarian Cancer. These sales forecasts leverage data on pharmaceutical sales and drug availability from GlobalData’s World Markets Healthcare (WMH) and POLI Price Intelligence databases. Ovarian Cancer is one of the most lethal ... Read More
-
Global Cancer Profiling Market Assessment, By Biomarker Type [Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers], By Technology [Immunoassays, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Microarray, Spectroscopic Method, Others], By Cancer Type [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Other Cancer], By Application [Clinical Application, Research Application], By End-user [Hospital Associated Diagnostic Laboratories, Diagnostic Centers, Cancer Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
... Cancer Type [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Other Cancer], By Application [Clinical Application, Research Application], By End-user [Hospital Associated Diagnostic Laboratories, Diagnostic Centers, ... Read More
-
Cancer biologics Global Market Report 2024
... Cancer; Colorectal Cancer; Gastric Cancers3) By Distribution Channel: Hospitals; ClinicsCovering: AbbVie Inc.; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Eli Lilly and Company; AmgenInc. Cancer biologics Global Market Report 2024 from The Business Research Company provides ... Read More
-
Multi-Cancer Diagnostic Tests: Global Market Outlook
... of the drivers and challenges in the market. The report also covers market projections for 2028. The report details the market share of MCD tests based on type and end user. The market is segmented ... Read More
-
Breast Cancer Monoclonal Antibodies Global Market Report 2024
... Covering: Amgen Inc.; Mylan N.V.; Merck & Co. Inc.; Novartis AG; GlaxoSmithKline plc. Breast Cancer Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Global POC Analyzers for Cancer Market Growth 2024-2030
... at a CAGR of % from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “POC Analyzers for Cancer Industry Forecast” looks at past sales and reviews total world POC Analyzers for ... Read More
-
Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region- Global Forecast to 2028
... home healthcare market is projected to reach USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, at a CAGR of 8.9% during the forecast period. The primary driver of growth in this market ... Read More
-
North America Cancer Diagnostics Market, By Products (Instruments, Consumables Services), By Test Type (Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Immunohistochemistry, In Situ Hybridization and Others (Endoscopy, Genetic Tests)), By Application (Breast Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United ... Read More
-
Kaposi Sarcoma Market Forecasts to 2030 – Global Analysis By Type (Classic Kaposi Sarcoma, Endemic Kaposi Sarcoma, Epidemic Kaposi Sarcoma, Immunosuppression-Associated Kaposi Sarcoma, Latrogenic Kaposi Sarcoma, Disseminated Kaposi Sarcoma and Other Types), Diagnostic Method, Treatment Modality, End User and By Geography
... Modality, End User and By Geography According to Stratistics MRC, the Global Kaposi Sarcoma Market is accounted for $108.69 million in 2023 and is expected to reach $150.92 million by 2030 growing at a CAGR ... Read More
-
Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
... according to Renub Research. In modern-day healthcare, lung cancer diagnostics are pivotal in early detection and personalized treatment. Advanced imaging strategies like CT scans and MRI permit particular identification of tumors and metastases, assisting in ... Read More
-
Genomics In Cancer Care Global Market Report 2024
... By End-user: Hospitals; Government Institutes; Research FacilitiesCovering: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V. Genomics In Cancer Care Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Global Anticancer Drugs Market Research Report 2024
... during the forecast period 2024-2030. North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the ... Read More
-
Advanced Renal Cell Carcinoma- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034
... RR-FL; however, follow-up remains limited. Identifying appropriate patients for CAR T-cell therapy stands out as a paramount challenge, given its expensive nature and aggressive treatment approach. The FDA has approved four CAR-Ts in different subtypes ... Read More
-
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034
... crucial retinal components such as retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris in the macula. Although this condition is not uncommon in clinical practice, it can go undetected until the atrophy involves the fovea and ... Read More
-
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034
... million, which is further expected to increase by 2034. In September 2023, concizumab was approved in Japan under the brand name ALHEMO for treating hemophilia A and B with inhibitors. Novo Nordisk expects to launch ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Cancer Biomarker Global Market Report 2024
... Cancer; Thyroid Cancer; Kidney Cancer4) By Application: Diagnostics; Research And Development; Prognostics; Risk AssessmentCovering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; QIAGEN NV; Illumina Inc.; Bio-Rad Laboratories Inc. Cancer Biomarker Global Market Report 2024 ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032
... for approximately USD 1,300 million, which is further expected to increase by 2034. Epidermolysis bullosa simplex (EBS) is the least severe type of epidermolysis bullosa, and many individuals with EBS may experience improvements as they ... Read More
Research Assistance
